- Home
- KELYA vs PHAT Comparison
KELYA vs PHAT Comparison
Compare KELYA & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KELYA
- PHAT
- Stock Information
- Founded
- KELYA 1946
- PHAT 2018
- Country
- KELYA United States
- PHAT United States
- Employees
- KELYA N/A
- PHAT N/A
- Industry
- KELYA Professional Services
- PHAT Biotechnology: Pharmaceutical Preparations
- Sector
- KELYA Consumer Discretionary
- PHAT Health Care
- Exchange
- KELYA Nasdaq
- PHAT Nasdaq
- Market Cap
- KELYA 403.0M
- PHAT 289.0M
- IPO Year
- KELYA N/A
- PHAT 2019
- Fundamental
- Price
- KELYA $12.38
- PHAT $3.12
- Analyst Decision
- KELYA Buy
- PHAT Strong Buy
- Analyst Count
- KELYA 1
- PHAT 5
- Target Price
- KELYA $25.00
- PHAT $17.80
- AVG Volume (30 Days)
- KELYA 249.3K
- PHAT 1.7M
- Earning Date
- KELYA 05-08-2025
- PHAT 05-01-2025
- Dividend Yield
- KELYA 2.46%
- PHAT N/A
- EPS Growth
- KELYA N/A
- PHAT N/A
- EPS
- KELYA N/A
- PHAT N/A
- Revenue
- KELYA $4,451,600,000.00
- PHAT $81,859,000.00
- Revenue This Year
- KELYA $9.54
- PHAT $201.74
- Revenue Next Year
- KELYA $3.92
- PHAT $114.16
- P/E Ratio
- KELYA N/A
- PHAT N/A
- Revenue Growth
- KELYA N/A
- PHAT 3055.70
- 52 Week Low
- KELYA $10.80
- PHAT $2.21
- 52 Week High
- KELYA $23.85
- PHAT $19.71
- Technical
- Relative Strength Index (RSI)
- KELYA 61.41
- PHAT 25.16
- Support Level
- KELYA $10.92
- PHAT $4.06
- Resistance Level
- KELYA $11.80
- PHAT $4.45
- Average True Range (ATR)
- KELYA 0.40
- PHAT 0.34
- MACD
- KELYA 0.18
- PHAT -0.15
- Stochastic Oscillator
- KELYA 97.59
- PHAT 3.57
About KELYA Kelly Services Inc.
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.